Clinical Trials on Alzheimer’s Disease (CTAD)
Clinical Trial in MCI Reducing Hippocampal Overactivity: HOPE4MCI AgeneBio’s Michela Gallagher and Sharon Rosenzweig-Lipson to present in Barcelona on Saturday, November 7, 2015, at 11:45 am
Posts for category: Events
BIO Investor Forum
October 20-21, 2015, San Francisco, CA. CEO Jerry McLaughlin will speak on Wednesday, October 21, at 9 am Pacific time.
USAgainstAlzheimer’s Summit
AgeneBio’s Michela Gallagher spoke on the impact and role of NIH funding on advances in science and clinical trials targeting the prevention of Alzheimer’s disease on Wednesday, September 30, 2015, in Washington, DC.
7th Annual Biotech Showcase 2015
January 12 – 14, 2015, San Francisco, CA. CEO Jerry McLaughlin spoke on Tuesday, January 13.